DAHANCA 10 - a randomized study of Aranesp as modifier of radiotherapy in patients with primary HNSCC - the Danish Head and Neck Cancer Group DAHANCA 10 randomized trials

Autor: Overgaard, J., Hoff, C. M., Sand Hansen, H., Specht, L., Overgaard, M., Cai Grau, Andersen, E., Jørgen Johansen, L, Andersen, Evensen, J. F.

Publikováno v: Overgaard, J, Hoff, C M, Hansen, H S, Specht, L, Overgaard, M, Grau, C, Andersen, E, Johansen, J, Andersen, L & Evensen, J F 2008, ' DAHANCA 10-a randomized study of Aranesp as modifier of radiotherapy in patients with primary HNSCC-the Danish Head and Neck Cancer Group DAHANCA 10 randomized trials ', 7th International Conference on Head and Neck Cancer, San Francisco, United States, 19/07/2008-23/08/2008 .
University of Southern Denmark

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::51debb06ccab6f2abe715ad40e4d6df8
https://portal.findresearcher.sdu.dk/da/publications/b757ca40-accd-11dd-9b31-000ea68e967b

Treatment of nasopharyngeal cancer in Denmark and outcome: results.

Autor: Sand hansen, H.¹, Overgaard, J.², Vendelboe johansen, L.², Bastholt, L.³

Publikováno v: Clinical Otolaryngology & Allied Sciences. Feb2000, Vol. 25 Issue 1, p80-80. 1p.

1065 A randomized trial with 1485 patients evaluating the importance of accelerated versus conventional fractionated radiotherapy in squamous cell carcinoma of the head and neck. Final results of the DAHANCA 6&7 study

Autor: Overgaard, J., Sand Hansen, H., Overgaard, M., Grau, C., Specht, L., Andersen, E., Bastholt, L., Hansen, O., Andersen, L., Evensen, J.

Publikováno v: In EJC Supplements 2003 1(5):S318-S318

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.